arrow
D

Dan M. Roden

Mass General Brigham
H指数:147
被引数:9.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prioritizing Discovery and Advancements in Arrhythmia Therapies NIH/NHLBI Workshop

优先考虑心律失常治疗领域的发现与进展:NIH/NHLBI研讨会

2026-06-010
PRE
Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease

室性传导是SCN5A-E1784K重叠钠通道疾病中心律失常风险的标志物

2026-05-110
OA
Multi-scale data improves performance of machine learning model for long COVID identification

多尺度数据提高了用于长新冠识别的机器学习模型性能

2026-05-050
OAAI
The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR

家族性高胆固醇血症基因LDLR编码变异的功能景观

Science
IF45.8
2025-10-300
PRE
Genetic evaluation of early-onset atrial fibrillation: impact on patient management

早期发病心房颤动的遗传学评估:对病人管理的影响

2025-10-011
OAAI
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine

创建变异效应图谱以解决意义不明的变异并指导心血管医学

2025-09-010
PRE
Advancing the science of genomic learning healthcare systems

推进基因组学习型医疗系统的科学

2025-07-230
OA
Patient Decision Aids and Encounter Decision Aids Improve Shared Decision Making and Patient Knowledge About Stroke Prevention In Patients with Atrial Fibrillation

患者决策辅助工具和就诊决策辅助工具可改善房颤患者的共同决策制定及关于卒中预防的知识水平。

2024-11-120
PRE
Late Gadolinium Enhancement in the Basal Left Ventricle is Associated with Ventricular Arrhythmias in Patients with Pathogenic Titin Variants

基底左心室晚期钆增强与携带致病变异肌节蛋白变体的患者的心室心律失常相关

2024-11-120
PRE
Clinical Characteristics and Outcomes in Patients With Atrial Fibrillation and Pathogenic TTN Variants
2024-11-010
OAAI
Ablation for Atrial Fibrillation in Patients With Rare Pathogenic Variants in Cardiomyopathy and Arrhythmia Genes
2024-11-011
OAAI
Promise and Peril of a Genotype-First Approach to Mendelian Cardiovascular Disease
2024-10-181
PRE
Multisite Validation of a Functional Assay to Adjudicate SCN5A Brugada Syndrome-Associated Variants

裁定SCN5A Brugada综合征相关变异的功能测定的多位点验证

2024-08-011
PRE